MicrofluidX
Addressing the challenges of process control, scalability, and affordability in cell bioprocessing, especially for autologous cell and gene therapy.
General Information
BounceWatch is an independent company data service, not affiliated with MicrofluidX. To contact MicrofluidX, visit microfluidx.co.uk.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MicrofluidX compare?
A PDF of MicrofluidX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MicrofluidX soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About MicrofluidX
Taxonomy: cell bioprocessing, autologous cell therapy, gene therapy, process control, scalability, affordability, bioprocessing technology, bioprocessing innovation
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | £3.30M | 6 |
|
08 Dec 2022 |
| Funding Round | Undisclosed | 1 |
|
01 Mar 2022 |
| Seed Round | £1.40M | 3 |
|
21 Apr 2020 |
MicrofluidX Alternatives & Competitors
View All Alternatives
Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products
We are simplifying solid tumor cell therapy to unlock the next frontier of cancer therapies.
A clinical-stage biotech company developing autologous and allogeneic cell therapies for the treatme...
FAQ About MicrofluidX
Source: BounceWatch company record for MicrofluidX, https://bouncewatch.com/company/microfluidx, updated 27 December 2024. When citing, please name BounceWatch and link this page.
